Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement

Kamila Ociepa1, Marian Danilewicz2, Małgorzata Wągrowska-Danilewicz3

  • 1Department of Dermatology and Venereology, Medical University of Lodz, 90-674 Lodz, Poland.

Insights

The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is implicated in autoimmune bullous diseases. This study found elevated JAK/STAT protein expression in lesions, suggesting it as a therapeutic target.

Area of Science:

  • Immunology
  • Molecular Biology
  • Dermatology

Background:

  • The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway regulates cell functions and is implicated in inflammatory and autoimmune diseases.
  • Limited research exists on JAK/STAT pathway involvement in autoimmune bullous diseases.

Purpose of the Study:

  • To investigate the expression of JAK3, STAT2, STAT4, and STAT6 proteins in oral mucosal lesions of patients with pemphigus vulgaris (PV), bullous pemphigoid (BP), oral lichen planus (LP), and chronic ulcerative stomatitis (CUS).
  • To compare protein expression in disease lesions against a healthy control group.

Main Methods:

  • Immunohistochemistry and immunoblotting techniques were employed.
  • Expression levels of JAK3, STAT2, STAT4, and STAT6 were quantified in epithelial lesions.

Main Results:

  • Significantly higher expression of selected JAK/STAT pathway proteins was observed in the lesions of PV, BP, LP, and CUS patients compared to controls.
  • Elevated STAT2 expression was not found in bullous pemphigoid (BP) and pemphigus vulgaris (PV) lesions.
  • Elevated STAT4 expression was not observed in chronic ulcerative stomatitis (CUS) and oral lichen planus (LP) lesions.
  • Distinct expression patterns of JAK/STAT proteins were noted across the studied autoimmune bullous diseases.

Conclusions:

  • The JAK/STAT pathway plays a role in the pathogenesis of autoimmune bullous diseases.
  • The observed differences in protein expression suggest specific roles for JAK/STAT proteins in different conditions.
  • These findings highlight potential new therapeutic targets for treating autoimmune bullous diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K